Human Growth Hormone (HGH or Growth Hormone GH) has been shown, in multiple studies, to be beneficial for those with Prader-Willi Syndrome (PWS). The use of Growth Hormone has become standard care when prescribed by an experienced endocrinologist. Growth Hormone was first approved in the United States in 2000 for patients with PWS. Other countries soon followed.
Growth Hormone is effective in increasing height, increasing muscle mass, decreasing body fat, improving weight distribution, increasing stamina and increasing bone mineral density. In addition, studies suggest positive effects on development, behavior and intellectual capability.
There is evidence that Growth Hormone treatment improves cognitive performance. Children who have been on Growth Hormone prior to the age of 4 years, show an increase in IQ over the historic average. Adults who have been treated with Growth Hormone have shown improvement in mental speed, mental flexibility and motor performance.
Although Growth Hormone does not decrease the appetite, this treatment – together with early intervention therapies – have helped to create a whole new generation of children with PWS who are taller, slimmer, more active, more alert, and who are living much healthier lives.